Rosemary often steals the headlines when it comes to strengthening hair health and stimulating hair growth. For decades, this aromatic herb has received praise for its ability to thicken hair and ward off thinning. And while rosemary certainly gets its due, there may be another herb that stands a better chance of improving hair health: ginseng. This age-old root is prized for its widespread benefits for health but has become part of the hair care regimen as a result of its strong influences on encouraging hair growth and scalp wellness.
For ages, ginseng is used as an effective adaptogen: this plant enhances general wellness, decreases stress, and boosts mental functioning. Newer research has shown another excellent advantage of ginseng: its promotion of hair growth. Most people have heard of ginseng in the Chinese traditional healing practices, but only over the last decade have researchers started to analyze it on a deeper level and look into its hair-related impacts. As it turns out, this humble root may hold the key to not just healthier hair, but more voluminous, thicker locks.
While genetics undeniably play a significant role in hair loss and thinning, factors such as stress, diet, scalp health, and circulation are all contributing elements that can exacerbate these conditions. This is where ginseng comes into play. It enhances the circulation of blood on its scalp, hence becomes fundamental in hair development and stimulating healthy growth in nourishing the scalp. That more blood flows into it thus enables the strong transport nutrients to the follicle site.
Recent studies have proven that ginseng is a potent herb that promotes hair growth. Red ginseng extract may significantly enhance hair growth, according to a study conducted in the Journal of Medicinal Food. It is crucial for those individuals who experience hair thinning or alopecia because such a discovery opens up a new window of possibilities through natural, herbal interventions.
Active ingredients of ginseng, especially ginsenosides, are considered to play a crucial role in this process. Ginsenosides enhance blood circulation towards the scalp, thereby stimulating hair follicles and increasing keratin production. The latter is a protein responsible for hair strength and structure. Moreover, the mentioned compounds inhibit the action of 5-alpha reductase, which causes male pattern baldness and female pattern hair loss. This helps ginseng in reducing the conversion of testosterone into dihydrotestosterone, a hormone that is responsible for hair loss.
Also Read: This Surprising Chilled Item Can Give You Shiny, Smooth Hair
Aside from promoting hair growth, ginseng also offers a variety of other benefits that can help in creating a healthier scalp and stronger hair. Here are some reasons why ginseng should be part of your hair care routine:
Ginseng is full of antioxidants, which protect your hair from free radicals with harmful oxidative effects. In other words, these little molecules bring about oxidative damage, hair breakage and thinning, and unnatural aging of hair. All these problems are neutralized by powerful antioxidants in Ginseng from the inside hair cells outwards.
Ginseng has natural antimicrobial properties that keep the scalp clean and healthy. This is important in keeping conditions such as dandruff, seborrheic dermatitis, and folliculitis away from the scalp, thus impeding hair growth. A clean and balanced scalp ensures that hair follicles are not obstructed to create an optimal environment for hair to grow.
Another property that is being provided by ginseng is to balance the scalp's natural oils. With fatty acids, it hydrates the scalp without getting greasy, making it ideal for people with both dry and oily scalps. This moisture balance will prevent hair breakage and split ends.
Stress is one of the most significant causes of hair loss, and ginseng is known to have an adaptogenic property. That is, it will make your body capable of resisting the effects of stress much more effectively. Ginseng would indirectly lead to a healthy scalp, as less stress would impact the body. This indirectly minimizes the chances of hair thinning due to the effect of stress factors.
If you want to add ginseng to your hair care process, then there are different ways through which you can do that. Many companies now create hair care products with added ginseng extract: shampoos, conditioners, hair masks- all of it. Thus, you'll be using ginseng without doing much.
Others prefer direct application of the ginseng-infused oils right on the scalp. However, pure ginseng oil can be quite strong, and blending it with a carrier oil like coconut or jojoba oil is suggested for the best results. Just apply this mixture to the scalp and massage it very gently to stimulate blood circulation and nourish the roots of the hair. The oil should be kept for an hour before it should be washed off the oily hair.
Another option is to create a nourishing ginseng hair mask. Combine ginseng powder with olive oil to create a mask that you can apply to your scalp. Leave it on for 20-30 minutes before rinsing thoroughly. This mask not only nourishes the scalp but also helps to repair damaged strands and improve overall hair health.
As with any hair care regimen, consistency is key when using ginseng for hair growth. To see the best results, these ginseng-based products should be used two or three times a week. One must be patient while using ginseng; hair growth is slow and gradual. If one suffers from hair thinning and scalp problems even after consuming ginseng, a visit to a dermatologist or trichologist to determine the underlying conditions will be advisable.
Whereas rosemary has long been the darling of herb enthusiasts claiming to help your hair grow, ginseng has emerged as one of the most powerful tools in the quest for healthy, thick hair. Through its properties of enhancing circulation, feeding the scalp with nutrients, and stimulating growth, ginseng proves to be an excellent remedy for people looking to get healthier-looking hair. Whether you use a commercially available product or make your own DIY treatments, you can enjoy great long-term benefits from ginseng when added to your hair care routine. The good news? It's completely natural and very effective as it supports the overall health of your scalp while fostering thicker, fuller hair.
Active ginseng components in cognitive impairment. Oncotarget. 2018
Antifatigue effects of Panax ginseng. PLoS One. 2013
Credit: AI
Irritable bowel syndrome (IBS) is often characterised by digestive symptoms like abdominal pain, bloating, constipation and diarrhoea. However, the condition involves more than the digestive system.
A new review published in The Lancet explains how interactions between the gut and brain, changes in the gut microbiome, immune activity and the body's response to pain can contribute to the development of symptoms.
The review, titled Irritable bowel syndrome and related disorders of gut-brain interaction, brings focuses on biological and psychological evidence behind IBS. Researchers describe it as a disorder of gut-brain interaction, in which signals between the digestive system and the central nervous system affect gut function.
The authors also discuss chronic constipation and functional diarrhoea, which belong to the bigger group of disorders related to gut-brain interaction. These conditions may affect an estimated 20% of the global population.
Also read: Olympian Ciara Mageean Dies At 34 After Bowel Cancer Battle: Warning Signs In Young Adults
The gut and brain communicate continuously through a complex network that involves the central nervous system, autonomic nervous system, enteric nervous system and hypothalamic-pituitary-adrenal (HPA) axis.
The brain can influence intestinal movement, secretion and sensitivity, while signals from the gut can affect how the brain processes pain and other sensations.
In people with IBS, this communication may become disrupted. The result can be changes in bowel movements, more sensitivity to normal digestive processes and abdominal discomfort.
The authors said, “These central and peripheral mechanisms can act in an integrated way to cause IBS symptoms, via the gut-brain axis.”
For instance, a person with IBS may experience pain or bloating even when the amount of gas or intestinal movement would not cause discomfort in someone without the condition. This is due to a condition called visceral hypersensitivity, in which the nerves supplying the digestive organs become unusually sensitive to internal sensations.
The review explains that changes in both peripheral mechanisms within the gut and central mechanisms involving the brain can contribute to symptoms.
Also read: Can Coffee Trigger Irritable Bowel Syndrome?
The gut microbiome, which consists of microorganisms living in the digestive tract, is another important part of the gut-brain connection.
Changes in the composition and activity of gut bacteria may impact intestinal function, immune responses and communication with the nervous system. The review identifies the following:
Psychological health is another component of the gut-brain axis. Stress, anxiety and other psychological difficulties can influence how the brain processes pain and communicates with the digestive system.
The HPA axis, which helps regulate the body's response to stress, plays a role in this process . Changes in stress levels can affect gut movement, secretion and sensitivity.
Currently, there is no single biomarker that can diagnose IBS. Doctors assess symptoms, medical history and clinical findings, while using tests to rule out other conditions.
The review highlights that some underlying mechanisms can already be measured through approved tests and questionnaires. These include abnormal bile acid metabolism, accelerated movement of contents through the colon and psychological conditions.
Credit: iStock
Does a patient’s chances of serious outcomes differ if they are treated by a female doctor? A recent study looks into this hypothesis to ascertain the difference between chances of a patient dying under a male and a female doctor.
According to the study, hospitalised patients treated by female doctors have a lower risk of dying within 30 days. They are also less likely to be re-hospitalised than those treated by male doctors. The study is published in JAMA Network Open.
"Past research has largely focused on surgical patients and the admitting physician only. Our findings add to the growing body of research examining the relationship between physician sex and patient outcomes, broadening the evidence beyond surgical care to a wider range of medical conditions and other physicians," says Dr. Angela Jerath, an ICES scientist, and Associate Professor, Department of Anesthesiology & Pain Medicine at the University of Toronto's Temerty Faculty of Medicine.
After analysing the health records of 958,150 adults admitted to hospitals in Ontario, Canada, between 2008 and 2022, researchers found that the 30-day mortality rate was 12.3% among patients treated by female physicians, compared to 13.7% among those treated by male physicians.
The findings also show a small difference in hospital readmissions. The 30-day readmission rate was 18.6% for patients treated by female doctors and 18.9% for those treated by male doctors.
The researchers examined outcomes across seven common medical conditions, including heart attacks, pneumonia and other acute illnesses.
They also considered the number of hospital days during which patients received care from female doctors, recognising that several doctors may be involved in a patient's treatment during an admission.
Also read: Manosphere Is A Public Health Concern: Lancet Report Says Online Misogyny Harms Men's Mental Health
After accounting for patient, physician and hospital characteristics, treatment by a female physician was linked with 12% lower adjusted odds of death within 30 days compared to treatment by a male physician.
The researchers also found that for every 10% increase in the proportion of hospital days managed by female physicians, the adjusted odds of 30-day mortality decreased by 7%. This was observed for most medical conditions that were studied. Atrial fibrillation was the only exception.
The difference in mortality was also seen at longer follow-up periods. Patients treated by female physicians had lower mortality at 90 days and one year.
The findings were observed among both male and female patients. Female patients treated by female physicians had the lowest adjusted 30-day mortality rate in the analysis.
The study did not establish why patients treated by female physicians experienced better outcomes. However, the researchers discussed possible differences in clinical practice and communication.
Female physicians may be more likely to engage in patient-focused communication, spend more time with patients, follow clinical guidelines and involve colleagues in decision-making.
These practices could influence how symptoms are studied, treatment decisions are made and coordinated during hospitalisation.
"The goal is not to favour one group of physicians over another but to identify practices and behaviours that may help improve care across the health system," says Jerath.
"An important strength of this study is that, unlike surgical care, patients admitted to hospital for medical conditions are generally assigned physicians based on rotating schedules rather than patient or referring physician preferences, helping to minimize referral bias."
Credit: AI
Eli Lilly's experimental weight-loss drug retatrutide, being referred to as ‘Godzilla’, continues to outperform its rivals like Ozempic.
According to a recent head-to-head Phase 3 clinical trial involving adults with type 2 diabetes, it delivered more than twice the average weight loss achieved with Ozempic.
Participants who took the highest dose of retatrutide lost an average of 20.9% of their body weight over 80 weeks, compared to 9.4% among those receiving Ozempic's highest approved dose for type 2 diabetes.
The trial, called TRANSCEND-T2D-2, involved more than 1,000 adults with type 2 diabetes. It compared once-weekly injections of retatrutide at doses of 9 mg and 12 mg with semaglutide, the active ingredient in Ozempic, at 2 mg.
At the end of 80 weeks, participants taking retatrutide 9 mg lost an average of 44.3 pounds (20.1 kg), while those receiving the 12 mg dose lost 47.4 pounds (21.5 kg). The Ozempic group lost an average of 20.9 pounds (9.5 kg).
The findings mark the first Phase 3 head-to-head comparison of retatrutide with another medicine in this class.
Also read: ‘Godzilla’ Drug Retatrutide Reverses Sleep Apnea In 1 In 4 Diabetes Patients
The trial found that retatrutide also resulted in produced greater reductions in HbA1c, a measure of average blood glucose over approximately three months.
At 80 weeks, participants taking either dose of retatrutide recorded an average HbA1c reduction of 2.2%, compared to 1.8 % among those receiving Ozempic.
The experimental drug also resulted in greater improvements in cardiovascular risk factors like non-HDL cholesterol, triglycerides and systolic blood pressure.
The most commonly reported side effects of retatrutide were gastrointestinal symptoms like diarrhoea, nausea, constipation, vomiting and indigestion.
Diarrhoea was reported in 28.3% of participants receiving the 9 mg dose and 32.7% receiving 12 mg, compared to 26.4% in the Ozempic group. Nausea occurred in 21.2%, 23.8% and 21.3% of participants, respectively.
Researchers also reported a higher incidence of dysesthesia, an abnormal sensation that can include tingling, burning or skin sensitivity, among participants taking retatrutide.
Treatment discontinuation because of side effects occurred in 4.8% of the 9 mg group and 7.9% of the 12 mg group, compared to 2.7% of the Ozempic group.
Retatrutide is a once-weekly injectable drug that targets three hormone receptors involved in regulating appetite, blood sugar and metabolism. They are GLP-1, GIP and glucagon.
GLP-1 helps regulate appetite and blood sugar while slowing the process of stomach emptying. GIP also plays a role in glucose regulation and insulin release. Glucagon is involved in controlling blood glucose and energy metabolism.
Ozempic, manufactured by Novo Nordisk, acts on the GLP-1 receptor. Eli Lilly's Mounjaro and Zepbound, which contain tirzepatide, target both GLP-1 and GIP receptors.
Retatrutide remains an investigational drug and has not been approved by the US Food and Drug Administration (FDA) or other regulatory authorities.
Eli Lilly plans to submit the drug for FDA approval in early 2027. The company said detailed results from the trial would be presented at a future medical meeting and published in a peer-reviewed journal.
© $2026 Times Horizon Private Limited